| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | TUBA3E TUBA4A TUBA3C TUBA1B VILL TUBA1A TUBA3D TUBA1C MYBPC1 | 1.36e-05 | 130 | 219 | 9 | GO:0005200 |
| GeneOntologyBiologicalProcess | cell junction organization | ABHD17A RELN DGKB ITGB4 CHRNB1 CHRNB2 PTK7 IQGAP1 NRP1 HMCN2 PTPRK TUBA1A PTPRS FER CACNA1A FKRP L1CAM GRIN2B SLC9A1 TENM4 ABHD17B LRP5 PRKCH IL1B TNS1 EPHA3 | 7.69e-06 | 974 | 211 | 26 | GO:0034330 |
| GeneOntologyCellularComponent | postsynaptic membrane | ABHD17A DGKB ITGB4 CHRNB1 CHRNB2 FBXO2 NRP1 PTPRS CNTN1 CACNA1A SYNE1 GRIA3 GRIN2B ABHD17B | 7.90e-05 | 405 | 214 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | ABHD17A DGKB ITGB4 CHRNB1 CHRNB2 FBXO2 NRP1 PTPRS CNTN1 CACNA1A SYNE1 L1CAM GRIA3 GRIN2B NCSTN ABHD17B RIMS1 | 1.12e-04 | 583 | 214 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK1 ABHD17A RELN IREB2 NCDN FBXO2 PTK7 NRP1 HMCN2 PTPRK BRS3 PTPRS BTD C4A C4B CACNA1A WFS1 SYNE1 L1CAM LMTK2 GRIA3 CASR GRIN2B ABHD17B TRIM9 MTOR EPHA3 | 1.49e-04 | 1228 | 214 | 27 | GO:0036477 |
| GeneOntologyCellularComponent | RAVE complex | 3.11e-04 | 3 | 214 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | neuronal cell body | PCSK1 RELN IREB2 NCDN PTK7 NRP1 HMCN2 PTPRK BRS3 PTPRS BTD C4A C4B CACNA1A L1CAM LMTK2 GRIA3 CASR GRIN2B MTOR | 3.87e-04 | 835 | 214 | 20 | GO:0043025 |
| MousePheno | premature bone ossification | 1.38e-05 | 26 | 171 | 5 | MP:0003416 | |
| Domain | Alpha_tubulin | 1.63e-10 | 9 | 212 | 6 | IPR002452 | |
| Domain | - | 6.76e-08 | 20 | 212 | 6 | 3.30.1330.20 | |
| Domain | - | 9.38e-08 | 21 | 212 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.28e-07 | 22 | 212 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.28e-07 | 22 | 212 | 6 | IPR018316 | |
| Domain | - | 1.28e-07 | 22 | 212 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.28e-07 | 22 | 212 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.71e-07 | 23 | 212 | 6 | IPR008280 | |
| Domain | Tubulin_C | 1.71e-07 | 23 | 212 | 6 | IPR023123 | |
| Domain | TUBULIN | 1.71e-07 | 23 | 212 | 6 | PS00227 | |
| Domain | Tubulin | 1.71e-07 | 23 | 212 | 6 | IPR000217 | |
| Domain | Tubulin | 1.71e-07 | 23 | 212 | 6 | SM00864 | |
| Domain | Tubulin_CS | 1.71e-07 | 23 | 212 | 6 | IPR017975 | |
| Domain | FN3 | ITGB4 KIAA0319 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 EPHA3 MYBPC1 | 2.01e-07 | 185 | 212 | 13 | SM00060 |
| Domain | Tubulin_FtsZ_GTPase | 2.26e-07 | 24 | 212 | 6 | IPR003008 | |
| Domain | Tubulin | 2.26e-07 | 24 | 212 | 6 | PF00091 | |
| Domain | fn3 | ITGB4 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 EPHA3 MYBPC1 | 3.39e-07 | 162 | 212 | 12 | PF00041 |
| Domain | FN3_dom | ITGB4 KIAA0319 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 EPHA3 MYBPC1 | 8.13e-07 | 209 | 212 | 13 | IPR003961 |
| Domain | FN3 | ITGB4 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 EPHA3 MYBPC1 | 3.00e-06 | 199 | 212 | 12 | PS50853 |
| Domain | PTPc_motif | 5.44e-05 | 59 | 212 | 6 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.44e-05 | 59 | 212 | 6 | IPR003595 | |
| Domain | - | 8.51e-05 | 92 | 212 | 7 | 3.90.190.10 | |
| Domain | Galactose-bd-like | 9.76e-05 | 94 | 212 | 7 | IPR008979 | |
| Domain | PKD/Chitinase_dom | 1.15e-04 | 9 | 212 | 3 | IPR022409 | |
| Domain | PKD | 1.15e-04 | 9 | 212 | 3 | SM00089 | |
| Domain | Rav1p_C | 1.28e-04 | 2 | 212 | 2 | IPR022033 | |
| Domain | Rav1p_C | 1.28e-04 | 2 | 212 | 2 | PF12234 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.35e-04 | 99 | 212 | 7 | IPR029021 | |
| Domain | ConA-like_dom | ADGRV1 ITGB4 NRP1 PTPRK SEL1L3 COL11A1 COL12A1 PTPRU TRIM9 SPRYD3 | 2.08e-04 | 219 | 212 | 10 | IPR013320 |
| Domain | PKD | 2.22e-04 | 11 | 212 | 3 | PS50093 | |
| Domain | PKD_dom | 2.22e-04 | 11 | 212 | 3 | IPR000601 | |
| Domain | - | 2.22e-04 | 11 | 212 | 3 | 2.60.40.670 | |
| Domain | VWFA | 3.40e-04 | 82 | 212 | 6 | PS50234 | |
| Domain | Mtf2_C_dom | 3.82e-04 | 3 | 212 | 2 | IPR025894 | |
| Domain | Mtf2_C | 3.82e-04 | 3 | 212 | 2 | PF14061 | |
| Domain | VWA | 3.88e-04 | 84 | 212 | 6 | SM00327 | |
| Domain | Ig-like_fold | HLA-DOA HLA-DRA ITGB4 PTK7 KIAA0319 PXDN HMCN2 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 IGHG2 EPHA3 MYBPC1 | 4.56e-04 | 706 | 212 | 19 | IPR013783 |
| Domain | MAM_1 | 7.24e-04 | 16 | 212 | 3 | PS00740 | |
| Domain | Ubiquitin_3 | 7.58e-04 | 4 | 212 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 7.58e-04 | 4 | 212 | 2 | IPR028135 | |
| Domain | ANF_lig-bd_rcpt | 7.95e-04 | 37 | 212 | 4 | IPR001828 | |
| Domain | ANF_receptor | 7.95e-04 | 37 | 212 | 4 | PF01094 | |
| Domain | MAM | 8.72e-04 | 17 | 212 | 3 | SM00137 | |
| Domain | VWF_A | 9.29e-04 | 99 | 212 | 6 | IPR002035 | |
| Domain | Peripla_BP_I | 9.72e-04 | 39 | 212 | 4 | IPR028082 | |
| Domain | SH2 | 1.03e-03 | 101 | 212 | 6 | PF00017 | |
| Domain | MAM | 1.04e-03 | 18 | 212 | 3 | PF00629 | |
| Domain | MAM_dom | 1.04e-03 | 18 | 212 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.04e-03 | 18 | 212 | 3 | PS50060 | |
| Domain | PTPase_domain | 1.18e-03 | 41 | 212 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.18e-03 | 41 | 212 | 4 | PF00102 | |
| Domain | DCN-prot | 1.25e-03 | 5 | 212 | 2 | IPR014764 | |
| Domain | C1-set_C | 1.25e-03 | 5 | 212 | 2 | PF16196 | |
| Domain | MANEC | 1.25e-03 | 5 | 212 | 2 | SM00765 | |
| Domain | Anaphylatoxin_comp_syst | 1.25e-03 | 5 | 212 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.25e-03 | 5 | 212 | 2 | IPR001840 | |
| Domain | PONY_dom | 1.25e-03 | 5 | 212 | 2 | IPR005176 | |
| Domain | MHC_II_alpha | 1.25e-03 | 5 | 212 | 2 | SM00920 | |
| Domain | DCUN1 | 1.25e-03 | 5 | 212 | 2 | PS51229 | |
| Domain | PAD | 1.25e-03 | 5 | 212 | 2 | PF03068 | |
| Domain | PAD_N | 1.25e-03 | 5 | 212 | 2 | PF08526 | |
| Domain | PAD_M | 1.25e-03 | 5 | 212 | 2 | PF08527 | |
| Domain | PAD | 1.25e-03 | 5 | 212 | 2 | IPR004303 | |
| Domain | PAD_C | 1.25e-03 | 5 | 212 | 2 | IPR013530 | |
| Domain | MANSC_N | 1.25e-03 | 5 | 212 | 2 | IPR011106 | |
| Domain | Prot_Arg_deaminase_cen_dom | 1.25e-03 | 5 | 212 | 2 | IPR013733 | |
| Domain | PAD_N | 1.25e-03 | 5 | 212 | 2 | IPR013732 | |
| Domain | C1-set_C | 1.25e-03 | 5 | 212 | 2 | IPR032431 | |
| Domain | Cullin_binding | 1.25e-03 | 5 | 212 | 2 | PF03556 | |
| Domain | - | 1.44e-03 | 73 | 212 | 5 | 2.60.120.260 | |
| Domain | Tyr_Pase_AS | 1.44e-03 | 73 | 212 | 5 | IPR016130 | |
| Domain | Ig_I-set | 1.50e-03 | 190 | 212 | 8 | IPR013098 | |
| Domain | I-set | 1.50e-03 | 190 | 212 | 8 | PF07679 | |
| Domain | SH2 | 1.60e-03 | 110 | 212 | 6 | SM00252 | |
| Domain | SH2 | 1.68e-03 | 111 | 212 | 6 | PS50001 | |
| Domain | SH2 | 1.76e-03 | 112 | 212 | 6 | IPR000980 | |
| Domain | - | 1.76e-03 | 112 | 212 | 6 | 3.30.505.10 | |
| Domain | DUSP | 1.87e-03 | 6 | 212 | 2 | PF06337 | |
| Domain | MANSC | 1.87e-03 | 6 | 212 | 2 | PS50986 | |
| Domain | MHC_II_alpha | 1.87e-03 | 6 | 212 | 2 | PF00993 | |
| Domain | DUSP | 1.87e-03 | 6 | 212 | 2 | SM00695 | |
| Domain | MANSC_dom | 1.87e-03 | 6 | 212 | 2 | IPR013980 | |
| Domain | PKD/REJ-like | 1.87e-03 | 6 | 212 | 2 | IPR002859 | |
| Domain | REJ | 1.87e-03 | 6 | 212 | 2 | PF02010 | |
| Domain | Cupredoxin | 1.89e-03 | 22 | 212 | 3 | IPR008972 | |
| Domain | ANATO | 2.59e-03 | 7 | 212 | 2 | SM00104 | |
| Domain | DUSP | 2.59e-03 | 7 | 212 | 2 | PS51283 | |
| Domain | ANAPHYLATOXIN_2 | 2.59e-03 | 7 | 212 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.59e-03 | 7 | 212 | 2 | PS01177 | |
| Domain | MHC_II_a_N | 2.59e-03 | 7 | 212 | 2 | IPR001003 | |
| Domain | ANATO | 2.59e-03 | 7 | 212 | 2 | PF01821 | |
| Domain | - | 2.59e-03 | 7 | 212 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 2.59e-03 | 7 | 212 | 2 | IPR006615 | |
| Domain | Anaphylatoxin/fibulin | 2.59e-03 | 7 | 212 | 2 | IPR000020 | |
| Domain | C2_dom | 2.73e-03 | 164 | 212 | 7 | IPR000008 | |
| Domain | TYR_PHOSPHATASE_1 | 2.97e-03 | 86 | 212 | 5 | PS00383 | |
| Domain | Glycoside_hydrolase_SF | 3.06e-03 | 53 | 212 | 4 | IPR017853 | |
| Domain | TYR_PHOSPHATASE_dom | 3.13e-03 | 87 | 212 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 3.13e-03 | 87 | 212 | 5 | PS50056 | |
| Domain | HP | 3.43e-03 | 8 | 212 | 2 | PS51089 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.29e-10 | 25 | 169 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.52e-10 | 17 | 169 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.95e-10 | 18 | 169 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.40e-09 | 19 | 169 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.40e-09 | 19 | 169 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.14e-09 | 20 | 169 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.14e-09 | 20 | 169 | 7 | M47911 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.98e-09 | 32 | 169 | 8 | M27491 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.17e-09 | 21 | 169 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.17e-09 | 21 | 169 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 4.61e-09 | 22 | 169 | 7 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 6.46e-09 | 35 | 169 | 8 | M47774 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 6.55e-09 | 23 | 169 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 6.55e-09 | 23 | 169 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 6.55e-09 | 23 | 169 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 9.16e-09 | 24 | 169 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.16e-09 | 24 | 169 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.26e-08 | 25 | 169 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.71e-08 | 26 | 169 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.71e-08 | 26 | 169 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.01e-08 | 28 | 169 | 7 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.67e-08 | 43 | 169 | 8 | M47669 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 3.93e-08 | 29 | 169 | 7 | M27948 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 4.44e-08 | 44 | 169 | 8 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.34e-08 | 45 | 169 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.40e-08 | 46 | 169 | 8 | M27828 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 8.22e-08 | 32 | 169 | 7 | M29848 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.03e-07 | 33 | 169 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.03e-07 | 33 | 169 | 7 | M47901 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.07e-07 | 49 | 169 | 8 | M891 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.02e-07 | 53 | 169 | 8 | M27651 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.90e-07 | 38 | 169 | 7 | M14981 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.53e-07 | 27 | 169 | 6 | MM15549 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 7.04e-07 | 43 | 169 | 7 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 8.29e-07 | 44 | 169 | 7 | M29830 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.03e-06 | 29 | 169 | 6 | MM15219 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.29e-06 | 17 | 169 | 5 | MM14731 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C GRIA3 GRIN2B | 1.84e-06 | 94 | 169 | 9 | M2843 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E TUBA4A TUBA3C NRP1 TUBA1B TUBA1A CNTN1 TUBA3D TUBA1C L1CAM | 1.89e-06 | 121 | 169 | 10 | M872 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.33e-06 | 51 | 169 | 7 | M26972 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A PIK3R2 TUBA3D TUBA1C ATG2B GRIN2B NCSTN MTOR LRP5 IL1B | 3.12e-06 | 261 | 169 | 14 | M42565 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 3.93e-06 | 55 | 169 | 7 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 4.45e-06 | 56 | 169 | 7 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.02e-06 | 57 | 169 | 7 | M27251 | |
| Pathway | REACTOME_KINESINS | 7.95e-06 | 61 | 169 | 7 | M977 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.22e-05 | 90 | 169 | 8 | M29841 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.52e-05 | 27 | 169 | 5 | MM15674 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | HLA-DOA HLA-DRA TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 2.05e-05 | 126 | 169 | 9 | M705 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.19e-05 | 71 | 169 | 7 | M39690 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.20e-05 | 48 | 169 | 6 | MM15353 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.28e-05 | 98 | 169 | 8 | M776 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.40e-05 | 72 | 169 | 7 | M26954 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.43e-05 | 76 | 169 | 7 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.43e-05 | 76 | 169 | 7 | M27215 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.62e-05 | 32 | 169 | 5 | MM14730 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C SH2B2 JMJD1C CBX5 | 3.83e-05 | 170 | 169 | 10 | M941 |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A PIK3R2 TUBA3D TUBA1C ATG2B GRIN2B NCSTN MTOR LRP5 IL1B | 3.84e-05 | 326 | 169 | 14 | M39379 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.36e-05 | 54 | 169 | 6 | M27482 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.41e-05 | 79 | 169 | 7 | M27743 | |
| Pathway | REACTOME_AGGREPHAGY | 6.51e-05 | 36 | 169 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 7.46e-05 | 37 | 169 | 5 | MM15102 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.65e-05 | 116 | 169 | 8 | MM15715 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 8.31e-05 | 20 | 169 | 4 | MM1383 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | TUBA3E TUBA4A TUBA3C CHRNB2 TUBA1B TUBA1A CACNA1A TUBA3D TUBA1C GRIA3 GRIN2B RIMS1 | 1.01e-04 | 270 | 169 | 12 | M15514 |
| Pathway | KEGG_GAP_JUNCTION | 1.02e-04 | 90 | 169 | 7 | M4013 | |
| Pathway | REACTOME_AUTOPHAGY | 1.20e-04 | 158 | 169 | 9 | M27935 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.43e-04 | 95 | 169 | 7 | M6729 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.61e-04 | 68 | 169 | 6 | MM14968 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | MAN2A2 TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C RAB3GAP1 IGF2R | 1.69e-04 | 203 | 169 | 10 | M27654 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.74e-04 | 44 | 169 | 5 | MM14606 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA3E TUBA4A TUBA3C CHRNB2 TUBA1B TUBA1A TUBA3D TUBA1C GRIA3 GRIN2B | 1.83e-04 | 205 | 169 | 10 | M752 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | RELN TUBA3E ADGRV1 TUBA4A TUBA3C NRP1 TUBA1B TUBA1A PIK3R2 PLCG1 CNTN1 COL6A1 TUBA3D TUBA1C L1CAM GRIN2B NCSTN EPHA3 | 1.88e-04 | 575 | 169 | 18 | M29853 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.97e-04 | 100 | 169 | 7 | M27650 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.09e-04 | 134 | 169 | 8 | M27751 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.23e-04 | 102 | 169 | 7 | M27648 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.38e-04 | 73 | 169 | 6 | MM15672 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | GDF5 CAPN14 ITGAL ITGB4 PXDN PTPRS COL6A1 COL11A1 COL12A1 EFEMP2 NCSTN SH3PXD2A | 2.69e-04 | 300 | 169 | 12 | M610 |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 2.97e-04 | 76 | 169 | 6 | M9052 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | RELN TUBA4A NRP1 TUBA1B TUBA1A PIK3R2 PLCG1 COL6A1 TUBA3D TUBA1C NCSTN | 3.11e-04 | 261 | 169 | 11 | MM15676 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.85e-04 | 52 | 169 | 5 | MM15211 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.85e-04 | 52 | 169 | 5 | MM14949 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | MAN2A2 TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C ST6GAL1 | 4.24e-04 | 187 | 169 | 9 | M961 |
| Pathway | REACTOME_NEURONAL_SYSTEM | TUBA3E TUBA4A TUBA3C CHRNB2 TUBA1B TUBA1A PTPRS KCNG1 CACNA1A TUBA3D TUBA1C GRIA3 GRIN2B RIMS1 | 4.34e-04 | 411 | 169 | 14 | M735 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.70e-04 | 151 | 169 | 8 | M550 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.90e-04 | 116 | 169 | 7 | MM14855 | |
| Pathway | REACTOME_KINESINS | 5.91e-04 | 57 | 169 | 5 | MM15714 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 6.94e-04 | 89 | 169 | 6 | M39398 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 8.07e-04 | 61 | 169 | 5 | M27103 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.41e-04 | 127 | 169 | 7 | M27181 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.26e-04 | 94 | 169 | 6 | MM14515 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 9.65e-04 | 130 | 169 | 7 | MM14627 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 9.67e-04 | 37 | 169 | 4 | MM14564 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.16e-03 | 66 | 169 | 5 | MM17074 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.21e-03 | 18 | 169 | 3 | M225 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.32e-03 | 68 | 169 | 5 | MM14921 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.37e-03 | 138 | 169 | 7 | M29805 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.49e-03 | 140 | 169 | 7 | M27550 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.61e-03 | 71 | 169 | 5 | MM15947 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | IL34 INPPL1 TUBA4A NOD2 TUBA1B TUBA1A PIK3R2 NFKBIB PLCG1 TUBA3D TUBA1C CSF2RB EBI3 IL1B | 1.65e-03 | 472 | 169 | 14 | MM14539 |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.71e-03 | 43 | 169 | 4 | M508 | |
| Pubmed | 1.44e-14 | 9 | 223 | 7 | 21167302 | ||
| Pubmed | 1.91e-11 | 19 | 223 | 7 | 15698476 | ||
| Pubmed | 1.91e-11 | 19 | 223 | 7 | 15691386 | ||
| Pubmed | 6.18e-11 | 6 | 223 | 5 | 3785200 | ||
| Pubmed | 6.37e-11 | 22 | 223 | 7 | 28117675 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 MAN2A2 GPAA1 PTDSS2 RXYLT1 ITGB4 DMXL1 PTK7 NRP1 THEM6 PXDN GLB1 PTPRK PTPRS BTD SEL1L3 C4A TIMELESS PIGO COL6A1 COL12A1 WFS1 FKRP L1CAM APEX1 ST6GAL1 NCSTN IGF2R LRP11 LRP5 | 2.27e-10 | 1201 | 223 | 30 | 35696571 |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 5.71e-10 | 8 | 223 | 5 | 16148047 | |
| Pubmed | 1.65e-09 | 4 | 223 | 4 | 18400243 | ||
| Pubmed | 4.45e-09 | 22 | 223 | 6 | 15103018 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.45e-09 | 22 | 223 | 6 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 7.91e-09 | 12 | 223 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.28e-08 | 13 | 223 | 5 | 10908577 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 ABCC3 STK36 MAN2A2 INPPL1 PFAS EDC4 ITGB4 NOD2 MDN1 PIK3C2B PLEKHM2 PTPRS KCNG1 PKD1 NLE1 PLCG1 C1orf50 CRYBG2 L1CAM LMTK2 MLLT10 SH2B2 IGF2R MTOR LRP5 | 1.35e-08 | 1105 | 223 | 26 | 35748872 |
| Pubmed | 1.98e-08 | 14 | 223 | 5 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 2.44e-08 | 6 | 223 | 4 | 7651436 | |
| Pubmed | 2.44e-08 | 6 | 223 | 4 | 16327313 | ||
| Pubmed | 5.67e-08 | 7 | 223 | 4 | 36681692 | ||
| Pubmed | 5.67e-08 | 7 | 223 | 4 | 11146551 | ||
| Pubmed | 6.02e-08 | 17 | 223 | 5 | 17360745 | ||
| Pubmed | GTPBP4 GALC NRP1 TUBA1B TUBA1A PLEKHM2 PTPRS KCNG1 PKD1 TUBA1C TFR2 | 1.89e-07 | 218 | 223 | 11 | 19460752 | |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.02e-07 | 9 | 223 | 4 | 11953448 | |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 11163133 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 11121746 | ||
| Pubmed | Interaction of phospholipase C-gamma1 with villin regulates epithelial cell migration. | 2.60e-07 | 3 | 223 | 3 | 16921170 | |
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.60e-07 | 3 | 223 | 3 | 9722999 | |
| Pubmed | 1.16e-06 | 210 | 223 | 10 | 16537572 | ||
| Pubmed | GTPBP4 USP11 PEG10 FASTKD5 PFAS NCDN DMXL1 PTK7 THEM6 MDN1 GLB1 PIK3R2 POP1 NLE1 BOP1 CLUH DMXL2 WFS1 SYNE1 TUBA1C PRPF8 CCDC61 LRPPRC RAB3GAP1 IGF2R CBX5 MRPL38 | 1.22e-06 | 1487 | 223 | 27 | 33957083 | |
| Pubmed | GTPBP4 EDC4 NCDN FBXO2 IQGAP1 KIAA0319 MDN1 PTPRS PEX5 CNTN1 CACNA1A DMXL2 SYNE1 GRIA3 GRIN2B LRPPRC IGF2R MTOR RIMS1 TNS1 LRRC15 | 1.23e-06 | 963 | 223 | 21 | 28671696 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 1.30e-06 | 54 | 223 | 6 | 21525035 | |
| Pubmed | MAN2A2 FASTKD5 TUBA1B PXDN GLB1 TUBA1A PTPRS SEL1L3 COL6A1 TUBA1C L1CAM NCSTN PRPF8 TFR2 LRPPRC IGF2R | 2.56e-06 | 613 | 223 | 16 | 22268729 | |
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 26601951 | ||
| Pubmed | MKRN3 KDM3A RELN USP11 PEG10 HLA-DRA IQGAP1 TUBA1B PTPRK USP32 PKD1 PLCG1 PJA1 DMXL2 SYNE1 EFEMP2 GRIN2B PRPF8 TRIM9 CIAO3 WIF1 PNMA2 MRPL38 PADI2 | 3.09e-06 | 1285 | 223 | 24 | 35914814 | |
| Pubmed | 5.13e-06 | 6 | 223 | 3 | 18613978 | ||
| Pubmed | 5.13e-06 | 6 | 223 | 3 | 12090300 | ||
| Pubmed | GTPBP4 USP11 PFAS EDC4 IQGAP1 MDN1 POP1 NLE1 BOP1 CLUH TUBA1C PRPF8 DIS3 LRPPRC IGF2R MTOR | 5.68e-06 | 653 | 223 | 16 | 22586326 | |
| Pubmed | 5.91e-06 | 19 | 223 | 4 | 18329113 | ||
| Pubmed | PPP1R12B DGKB EDC4 TUBA4A NCDN IQGAP1 TUBA1A PTPRS HECW2 C4A C4B CNTN1 CACNA1A DMXL2 SELENBP1 WFS1 SYNE1 TUBA1C L1CAM GRIN2B LRPPRC TENM4 TRIM9 RIMS1 TNS1 | 6.09e-06 | 1431 | 223 | 25 | 37142655 | |
| Pubmed | 6.57e-06 | 71 | 223 | 6 | 12754519 | ||
| Pubmed | 7.03e-06 | 257 | 223 | 10 | 16335952 | ||
| Pubmed | ITGB4 TUB NCDN ZRANB3 VILL POP1 DCAF17 BOP1 TIMELESS PLCG1 PJA1 AEN LMTK2 ST6GAL1 NCSTN DIS3 IGF2R ABHD17B CBX5 DEDD TNS1 | 7.64e-06 | 1084 | 223 | 21 | 11544199 | |
| Pubmed | 9.77e-06 | 76 | 223 | 6 | 27542412 | ||
| Pubmed | 1.05e-05 | 77 | 223 | 6 | 22973453 | ||
| Pubmed | GTPBP4 GPAA1 PEG10 TUBA4A TUBA1B THEM6 PXDN GLB1 POP1 NLE1 CLUH PIGO COL12A1 DCUN1D5 L1CAM APEX1 NCSTN PRPF8 TBC1D13 LRPPRC IGF2R ABHD17B MRPL38 | 1.16e-05 | 1297 | 223 | 23 | 33545068 | |
| Pubmed | 1.17e-05 | 164 | 223 | 8 | 32409323 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FASTKD5 PTDSS2 EDC4 NCDN PTK7 IQGAP1 THEM6 PXDN GLB1 PTPRK TIMELESS PJA1 WFS1 FKRP NCSTN LRPPRC RAB3GAP1 IGF2R MTOR | 1.21e-05 | 942 | 223 | 19 | 31073040 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP11 PFAS PTK7 THEM6 DUSP26 PTPRK PTPRS BOP1 PLCG1 CLUH NCSTN PTPRU PRPF8 CDC14A DIS3 LRPPRC MTOR PNMA2 PADI2 | 1.92e-05 | 974 | 223 | 19 | 28675297 |
| Pubmed | 2.12e-05 | 9 | 223 | 3 | 19103752 | ||
| Pubmed | 3.31e-05 | 94 | 223 | 6 | 36584595 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HLA-DRA ADGRV1 IQGAP1 DUSP26 GK GLB1 TUBA1A HP PKD1 VIL1 COL6A1 SELENBP1 NCSTN RAB3GAP1 IGF2R SLC12A3 PRKCH PADI2 LRRC15 | 3.40e-05 | 1016 | 223 | 19 | 19056867 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.50e-05 | 248 | 223 | 9 | 24006456 | |
| Pubmed | 3.85e-05 | 251 | 223 | 9 | 27507650 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 19062096 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 34859928 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.09e-05 | 2 | 223 | 2 | 17645767 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 12207352 | ||
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 4.09e-05 | 2 | 223 | 2 | 17102641 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 4.09e-05 | 2 | 223 | 2 | 27758680 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 4.09e-05 | 2 | 223 | 2 | 3037333 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 11726230 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 4216347 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 4.09e-05 | 2 | 223 | 2 | 8428773 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 4.09e-05 | 2 | 223 | 2 | 24268707 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 4.09e-05 | 2 | 223 | 2 | 21345967 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 2302180 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 22151770 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 29080553 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 4.09e-05 | 2 | 223 | 2 | 25339671 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 17728371 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 6149580 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 6149581 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 3542363 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 2387317 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 31262977 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 7365238 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 4.09e-05 | 2 | 223 | 2 | 17971229 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 24842051 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 35898513 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 28873507 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 11104662 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 3794341 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 22785613 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 4.09e-05 | 2 | 223 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 4.09e-05 | 2 | 223 | 2 | 3902619 | |
| Pubmed | Obligatory role for phospholipase C-gamma(1) in villin-induced epithelial cell migration. | 4.09e-05 | 2 | 223 | 2 | 17229814 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 4.09e-05 | 2 | 223 | 2 | 3839072 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 4.09e-05 | 2 | 223 | 2 | 7373044 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 4.09e-05 | 2 | 223 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 4.09e-05 | 2 | 223 | 2 | 16098595 | |
| Pubmed | Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. | 4.09e-05 | 2 | 223 | 2 | 32034158 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 4.09e-05 | 2 | 223 | 2 | 15787745 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 30026462 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 6559257 | ||
| Pubmed | L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. | 4.09e-05 | 2 | 223 | 2 | 16377081 | |
| Pubmed | IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo. | 4.09e-05 | 2 | 223 | 2 | 20975042 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 12480675 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 26800705 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 4.09e-05 | 2 | 223 | 2 | 1699796 | |
| Interaction | TCP11L2 interactions | 5.68e-08 | 21 | 210 | 6 | int:TCP11L2 | |
| Interaction | LYPD1 interactions | 2.31e-06 | 58 | 210 | 7 | int:LYPD1 | |
| Interaction | DUSP26 interactions | 2.60e-06 | 59 | 210 | 7 | int:DUSP26 | |
| Interaction | ST8SIA4 interactions | 2.69e-06 | 84 | 210 | 8 | int:ST8SIA4 | |
| Interaction | ASAH1 interactions | 4.17e-06 | 89 | 210 | 8 | int:ASAH1 | |
| Interaction | BRINP3 interactions | 5.25e-06 | 25 | 210 | 5 | int:BRINP3 | |
| Interaction | FBXO2 interactions | GPAA1 ADGRV1 FBXO2 PXDN PTPRK PTPRS BTD SEL1L3 CNTN1 COL6A1 COL12A1 WFS1 L1CAM NCSTN PTPRU IGF2R | 6.93e-06 | 411 | 210 | 16 | int:FBXO2 |
| Interaction | FBXO6 interactions | MAN2A2 FASTKD5 TUBA1B PXDN GLB1 TUBA1A PTPRS BTD SEL1L3 CHST7 COL6A1 COL12A1 TUBA1C L1CAM NCSTN PTPRU PRPF8 TFR2 LRPPRC IGF2R TENM4 | 2.07e-05 | 717 | 210 | 21 | int:FBXO6 |
| Interaction | CEACAM8 interactions | 3.55e-05 | 119 | 210 | 8 | int:CEACAM8 | |
| Interaction | BSG interactions | USP11 TUBA3E FASTKD5 EDC4 TUBA4A TUBA3C NRP1 TUBA1B GK MDN1 TUBA1A SAMD1 TUBA3D TUBA1C APEX1 NCSTN PRPF8 MTOR CBX5 | 3.59e-05 | 631 | 210 | 19 | int:BSG |
| Interaction | GRM7 interactions | 3.93e-05 | 19 | 210 | 4 | int:GRM7 | |
| Interaction | EFNA4 interactions | GPAA1 EDC4 THEM6 PXDN TUBA1A TIMELESS COL6A1 DMXL2 WFS1 LRRC15 EPHA3 | 4.40e-05 | 239 | 210 | 11 | int:EFNA4 |
| Interaction | CD48 interactions | 5.05e-05 | 39 | 210 | 5 | int:CD48 | |
| Interaction | TSPYL6 interactions | 7.62e-05 | 68 | 210 | 6 | int:TSPYL6 | |
| Interaction | CDHR4 interactions | 7.62e-05 | 68 | 210 | 6 | int:CDHR4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE14 SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE8 | 8.71e-06 | 271 | 225 | 9 | chr7q11 |
| Cytoband | 15q26.1 | 1.47e-04 | 54 | 225 | 4 | 15q26.1 | |
| Cytoband | 6q12-q13 | 2.37e-04 | 5 | 225 | 2 | 6q12-q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 4.55e-04 | 129 | 225 | 5 | chr2q35 | |
| Cytoband | 10p12 | 4.94e-04 | 7 | 225 | 2 | 10p12 | |
| Cytoband | 2q35 | 6.33e-04 | 79 | 225 | 4 | 2q35 | |
| Cytoband | 12q13.12 | 8.63e-04 | 38 | 225 | 3 | 12q13.12 | |
| Cytoband | 7q22 | 8.63e-04 | 38 | 225 | 3 | 7q22 | |
| Cytoband | 7q11.23 | 1.36e-03 | 97 | 225 | 4 | 7q11.23 | |
| GeneFamily | Tubulins | 1.12e-09 | 26 | 146 | 7 | 778 | |
| GeneFamily | Fibronectin type III domain containing | ITGB4 PTPRK PTPRS CNTN1 COL12A1 L1CAM PTPRU CSF2RB EBI3 TRIM9 EPHA3 MYBPC1 | 6.75e-09 | 160 | 146 | 12 | 555 |
| GeneFamily | Calcium sensing receptors | 6.48e-05 | 2 | 146 | 2 | 279 | |
| GeneFamily | SH2 domain containing | 1.69e-04 | 101 | 146 | 6 | 741 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.36e-04 | 161 | 146 | 7 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.17e-04 | 21 | 146 | 3 | 813 | |
| GeneFamily | Peptidyl arginine deiminases | 6.37e-04 | 5 | 146 | 2 | 677 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.76e-04 | 181 | 146 | 7 | 694 | |
| GeneFamily | Gelsolin/villins | 1.76e-03 | 8 | 146 | 2 | 950 | |
| GeneFamily | Fibulins | 1.76e-03 | 8 | 146 | 2 | 556 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.25e-03 | 9 | 146 | 2 | 1234 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 4.05e-03 | 12 | 146 | 2 | 756 | |
| GeneFamily | Low density lipoprotein receptors | 4.77e-03 | 13 | 146 | 2 | 634 | |
| GeneFamily | ATP binding cassette subfamily A | 5.53e-03 | 14 | 146 | 2 | 805 | |
| GeneFamily | Collagens | 6.08e-03 | 46 | 146 | 3 | 490 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 7.03e-06 | 200 | 217 | 10 | M7526 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 7.30e-06 | 33 | 217 | 5 | M7409 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | PCSK1 PEG10 CHRNB2 PTK7 NRP1 KIAA0319 DUSP26 TUBA1A QPCT CACNA1A CASR TM7SF2 | 1.25e-05 | 312 | 217 | 12 | M39161 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | DCUN1D4 ITGB4 TUBA4A USP32 DIO2 BOP1 C4A C4B CACNA1A COL6A1 DMXL2 CRYBG2 WFS1 NAA11 L1CAM LMTK2 SLC12A3 MTOR CIAO3 IL1B TNS1 | 2.40e-05 | 909 | 217 | 21 | M41018 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RELN ABCA13 DGKB ADGRV1 CNTN1 COL11A1 COL12A1 GRIN2B DNAH1 TENM4 MYO16 | 1.44e-10 | 184 | 220 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RELN ABCA13 DGKB ADGRV1 CNTN1 COL11A1 COL12A1 GRIN2B DNAH1 TENM4 MYO16 | 1.44e-10 | 184 | 220 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 RELN ABCA13 DGKB ADGRV1 CNTN1 COL11A1 COL12A1 GRIN2B DNAH1 TENM4 MYO16 | 1.44e-10 | 184 | 220 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | GLT1D1 ABCA13 IQGAP1 TUBA1A HECW2 USP32 JMJD1C IGF2R CSF2RB TRIM9 PADI2 MYO16 | 3.77e-10 | 200 | 220 | 12 | 95c41f147a1594d49e73cb56d86d301c3115ce20 |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | TRABD2B USP11 PTK7 PTPRS COL6A1 SELENBP1 GRIA3 CAMK1G IGF2R PNMA2 TNS1 | 3.18e-09 | 191 | 220 | 11 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | DGKB PTK7 PTPRS COL6A1 SELENBP1 GRIA3 IGF2R CBX5 PNMA2 TNS1 EPHA3 | 4.16e-09 | 196 | 220 | 11 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PEG10 DGKB NRP1 PXDN OLFML1 COL6A1 COL11A1 COL12A1 EFEMP2 TENM4 | 5.80e-08 | 198 | 220 | 10 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ADGRV1 TUBA4A FBXO2 KIAA0319 CFAP47 SELENBP1 WFS1 SYNE1 WIF1 MYBPC1 | 6.37e-08 | 200 | 220 | 10 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 165 | 220 | 9 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 165 | 220 | 9 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-07 | 172 | 220 | 9 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-07 | 173 | 220 | 9 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-07 | 174 | 220 | 9 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 180 | 220 | 9 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 180 | 220 | 9 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 180 | 220 | 9 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-07 | 181 | 220 | 9 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-07 | 181 | 220 | 9 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.54e-07 | 184 | 220 | 9 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 4.63e-07 | 190 | 220 | 9 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.51e-07 | 194 | 220 | 9 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | NRP1 PXDN OLFML1 COL6A1 COL11A1 COL12A1 EFEMP2 PPP1R27 LRRC15 | 5.51e-07 | 194 | 220 | 9 | 55b97095a7a17a312c616703d291738a0f806339 |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.54e-07 | 198 | 220 | 9 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-07 | 200 | 220 | 9 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 171 | 220 | 8 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 171 | 220 | 8 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-06 | 175 | 220 | 8 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 176 | 220 | 8 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.77e-06 | 176 | 220 | 8 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 176 | 220 | 8 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 177 | 220 | 8 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.01e-06 | 178 | 220 | 8 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.14e-06 | 179 | 220 | 8 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 3.40e-06 | 181 | 220 | 8 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 184 | 220 | 8 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 3.84e-06 | 184 | 220 | 8 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 184 | 220 | 8 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.00e-06 | 185 | 220 | 8 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 185 | 220 | 8 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-06 | 185 | 220 | 8 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.33e-06 | 187 | 220 | 8 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.51e-06 | 188 | 220 | 8 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 188 | 220 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.51e-06 | 188 | 220 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.51e-06 | 188 | 220 | 8 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.51e-06 | 188 | 220 | 8 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 188 | 220 | 8 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-06 | 189 | 220 | 8 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-06 | 189 | 220 | 8 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-06 | 189 | 220 | 8 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.69e-06 | 189 | 220 | 8 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.87e-06 | 190 | 220 | 8 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 4.87e-06 | 190 | 220 | 8 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 4.87e-06 | 190 | 220 | 8 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 191 | 220 | 8 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 191 | 220 | 8 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 5.26e-06 | 192 | 220 | 8 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.26e-06 | 192 | 220 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-06 | 137 | 220 | 7 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 5.47e-06 | 193 | 220 | 8 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 193 | 220 | 8 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 193 | 220 | 8 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 5.68e-06 | 194 | 220 | 8 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 196 | 220 | 8 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-06 | 197 | 220 | 8 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 390C-Myeloid-Dendritic|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.35e-06 | 197 | 220 | 8 | 424526c94b9a73c1c28ddc65dfba53aba5c6b2d2 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-06 | 198 | 220 | 8 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-06 | 198 | 220 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.84e-06 | 199 | 220 | 8 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.84e-06 | 199 | 220 | 8 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.84e-06 | 199 | 220 | 8 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.90e-06 | 142 | 220 | 7 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 7.10e-06 | 200 | 220 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.10e-06 | 200 | 220 | 8 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-06 | 200 | 220 | 8 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 7.10e-06 | 200 | 220 | 8 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.10e-06 | 200 | 220 | 8 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.10e-06 | 200 | 220 | 8 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.10e-06 | 200 | 220 | 8 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.10e-06 | 200 | 220 | 8 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 200 | 220 | 8 | 69295705fc614c2687f2b6c8e6aa0c6717841008 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-06 | 200 | 220 | 8 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.10e-06 | 200 | 220 | 8 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-06 | 200 | 220 | 8 | 0cb6e65f9efe1d4fd18b8ef4333cc39956cafdad | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.23e-06 | 143 | 220 | 7 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.79e-06 | 99 | 220 | 6 | c8fcfc92bcb0c19dc4aaf4e67d263b936d41d589 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-05 | 100 | 220 | 6 | 32219094edb6e3c81222d5fcfbf222b7fdc58fa3 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-05 | 152 | 220 | 7 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 154 | 220 | 7 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 154 | 220 | 7 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 156 | 220 | 7 | 21baf8c6e62bb7fd1530c2c100f73c0cecee092e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 156 | 220 | 7 | c841faa1695ff577b0774f531adf1343d05dce9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 158 | 220 | 7 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 158 | 220 | 7 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 158 | 220 | 7 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 160 | 220 | 7 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.70e-05 | 163 | 220 | 7 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 163 | 220 | 7 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 1.70e-05 | 163 | 220 | 7 | c8e4440d1a857e4da83002303940dd42b273c92e | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.70e-05 | 163 | 220 | 7 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| Computational | Adhesion molecules. | RELN ITGAL PTK7 NRP1 PTPRS COL6A1 COL11A1 COL12A1 EFEMP2 L1CAM | 1.77e-05 | 141 | 143 | 10 | MODULE_122 |
| Drug | Epothilone D | 5.50e-08 | 12 | 216 | 5 | DB01873 | |
| Drug | Epothilone B | 5.50e-08 | 12 | 216 | 5 | DB03010 | |
| Drug | DTAF | 1.24e-06 | 37 | 216 | 6 | CID000123934 | |
| Drug | SureCN13401588 | 1.69e-06 | 22 | 216 | 5 | CID009897422 | |
| Drug | procaine | TUBA3E TUBA4A CHRNB1 CHRNB2 GLB1 TUBA1A PKD1 CACNA1A TUBA1C PRKCH | 2.11e-06 | 153 | 216 | 10 | CID000004914 |
| Drug | NSC-373301 | 2.15e-06 | 23 | 216 | 5 | CID000341375 | |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; HL60; HT_HG-U133A | MKRN3 PDE4C ITGB4 CHRNB1 PLCG1 PADI1 COL6A1 DMXL2 ST6GAL1 GRIN2B FUT7 | 2.76e-06 | 195 | 216 | 11 | 6157_UP |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; HL60; HG-U133A | NCDN VILL PIK3C2B NFKBIB SEL1L3 TIMELESS DMXL2 EFEMP2 PTPRU IL1B TNS1 | 3.19e-06 | 198 | 216 | 11 | 1624_UP |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; HL60; HT_HG-U133A | PPP1R12B ADA2 VILL ANGPT4 NFKBIB TIMELESS CNTN1 COL6A1 CRYBG2 SH3PXD2A FUT7 | 3.19e-06 | 198 | 216 | 11 | 2918_UP |
| Drug | 1069C85 | 3.34e-06 | 25 | 216 | 5 | CID006918099 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 3.34e-06 | 4 | 216 | 3 | DB07574 | |
| Drug | 2-nitroimidazole | 4.04e-06 | 129 | 216 | 9 | CID000010701 | |
| Drug | NSC72302 | 6.04e-06 | 28 | 216 | 5 | CID000118078 | |
| Drug | NSC100058 | 6.59e-06 | 74 | 216 | 7 | CID000003449 | |
| Drug | AC1L1G95 | 1.20e-05 | 32 | 216 | 5 | CID000003583 | |
| Drug | epo906 | 1.34e-05 | 114 | 216 | 8 | CID000388945 | |
| Drug | vinblastine | ABCC3 TUBA3E ITGAL TUBA4A CHRNB1 CHRNB2 TUBA1B TUBA1A PKD1 TUBA1C | 1.38e-05 | 189 | 216 | 10 | CID000013342 |
| Drug | taltobulin | 1.40e-05 | 33 | 216 | 5 | CID006918637 | |
| Drug | AC1L8WWP | 1.49e-05 | 56 | 216 | 6 | CID000388944 | |
| Drug | NSC376450 | 1.63e-05 | 34 | 216 | 5 | CID000005605 | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.73e-05 | 194 | 216 | 10 | 4763_DN | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A | FBXO2 DUSP26 NFKBIB PADI1 COL6A1 AEN CRYBG2 MTF2 ABHD17B TNS1 | 1.89e-05 | 196 | 216 | 10 | 6372_UP |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A | GDF5 CHRNB2 FBXO2 KIAA0319 ANGPT4 NFKBIB CRYBG2 CDC14A TFR2 TENM4 | 1.89e-05 | 196 | 216 | 10 | 4106_UP |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.97e-05 | 197 | 216 | 10 | 3385_UP | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | GTPBP4 PTK7 NFKBIB PIGO COL6A1 SYNE1 EFEMP2 MLLT10 PRKCH DEDD | 1.97e-05 | 197 | 216 | 10 | 4608_DN |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | CHRNB2 NFKBIB PLCG1 CNTN1 CACNA1A COL6A1 FKRP SYNE1 LMTK2 TNS1 | 2.06e-05 | 198 | 216 | 10 | 3730_DN |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; HL60; HT_HG-U133A | PEG10 PXDN TIMELESS PLCG1 CNTN1 COL6A1 AEN EFEMP2 TFR2 EPHA3 | 2.06e-05 | 198 | 216 | 10 | 2526_UP |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | PTDSS2 DCUN1D4 NFKBIB NLE1 ATG2B MLLT10 DIS3 RAB3GAP1 PRKCH KLHL26 | 2.06e-05 | 198 | 216 | 10 | 7010_DN |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; PC3; HT_HG-U133A | ABCC3 ITGB4 PTK7 NFKBIB COL6A1 DIS3 RAB3GAP1 TM7SF2 PRKCH DEDD | 2.06e-05 | 198 | 216 | 10 | 4605_DN |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A | RXYLT1 THEM6 PIK3C2B BTD NFKBIB SEL1L3 QPCT ATG2B MLLT10 DEDD | 2.06e-05 | 198 | 216 | 10 | 2348_DN |
| Drug | paraquat | 2.15e-05 | 199 | 216 | 10 | CID000015938 | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | RELN PFAS CHRNB2 NFKBIB NLE1 PADI1 COL6A1 ATG2B TENM4 LRRC15 | 2.15e-05 | 199 | 216 | 10 | 603_DN |
| Drug | gadolinium | GALC ADGRV1 TUBA1B PKD1 CACNA1A APEX1 GRIA3 CASR GPRC6A NCSTN | 2.15e-05 | 199 | 216 | 10 | CID000023982 |
| Drug | compound 22 | 2.85e-05 | 38 | 216 | 5 | CID000205101 | |
| Drug | gnoscopine | 2.85e-05 | 38 | 216 | 5 | CID000004544 | |
| Drug | NSC339663 | TUBA3E ITGB4 TUBA4A TUBA1A FER PLCG1 VIL1 SYNE1 TUBA1C SLC9A1 MTOR | 2.87e-05 | 250 | 216 | 11 | CID000003892 |
| Drug | PIPES | 3.22e-05 | 64 | 216 | 6 | CID000079723 | |
| Drug | Dolastatin 10 | 3.25e-05 | 39 | 216 | 5 | CID000100208 | |
| Drug | bromocolchicine | 4.15e-05 | 21 | 216 | 4 | CID000161518 | |
| Drug | colchifoline | 4.15e-05 | 21 | 216 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 4.15e-05 | 21 | 216 | 4 | CID000164454 | |
| Drug | SRI-3072 | 4.15e-05 | 21 | 216 | 4 | CID000493469 | |
| Drug | lumicolchicine | 4.16e-05 | 41 | 216 | 5 | CID000072624 | |
| Drug | 3,4,5-trimethoxyacetophenone | 5.04e-05 | 22 | 216 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 5.04e-05 | 22 | 216 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 5.04e-05 | 22 | 216 | 4 | CID000098538 | |
| Drug | NSC119914 | 5.04e-05 | 22 | 216 | 4 | CID000274126 | |
| Drug | N-methyldemecolcine | 5.04e-05 | 22 | 216 | 4 | CID000023759 | |
| Drug | NSC-339672 | 5.04e-05 | 22 | 216 | 4 | CID000433930 | |
| Drug | Cortisporin | 5.09e-05 | 177 | 216 | 9 | CID000004454 | |
| Drug | AC1L1KMJ | TUBA3E TUBA4A IQGAP1 TUBA1A PIK3R2 PKD1 PLCG1 CNTN1 COL6A1 COL11A1 COL12A1 TUBA1C SLC9A1 MTOR PRKCH | 5.34e-05 | 476 | 216 | 15 | CID000030956 |
| Drug | 9-beta-D-arabinofuranosylguanine | GTPBP4 RELN PDE4C PPP1R12B IREB2 TUBA3E ITGB4 TUBA4A IQGAP1 GK TUBA1A BRS3 PIK3R2 NFKBIB POP1 C4A PLCG1 TUBA1C NCSTN MTOR PRKCH | 5.68e-05 | 843 | 216 | 21 | CID000000765 |
| Drug | N-methyl-DL-aspartic acid | RELN ADGRV1 CHRNB1 CHRNB2 FBXO2 PIK3R2 PKD1 C4A CACNA1A GRIA3 CAMK1G GRIN2B NCSTN MTOR PRKCH RIMS1 IL1B EPHA3 | 5.73e-05 | 655 | 216 | 18 | CID000004376 |
| Drug | Dale | 5.83e-05 | 71 | 216 | 6 | CID005486816 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 6.06e-05 | 23 | 216 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 6.06e-05 | 23 | 216 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 6.06e-05 | 23 | 216 | 4 | CID000125548 | |
| Drug | NSC355636 | 6.06e-05 | 23 | 216 | 4 | CID000100176 | |
| Drug | IKP104 | 6.06e-05 | 23 | 216 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 6.06e-05 | 23 | 216 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 6.06e-05 | 23 | 216 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 6.06e-05 | 23 | 216 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 6.06e-05 | 23 | 216 | 4 | CID000097865 | |
| Drug | methyl ether | 6.58e-05 | 45 | 216 | 5 | CID000008254 | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 6.87e-05 | 184 | 216 | 9 | 2946_UP | |
| Drug | parbendazole | 7.21e-05 | 24 | 216 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 7.21e-05 | 24 | 216 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 7.21e-05 | 24 | 216 | 4 | CID000330401 | |
| Drug | NABV | 7.21e-05 | 24 | 216 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 7.21e-05 | 24 | 216 | 4 | CID000163705 | |
| Drug | moscatilin | 7.21e-05 | 24 | 216 | 4 | CID000176096 | |
| Drug | NSC-36768 | 7.21e-05 | 24 | 216 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 7.21e-05 | 24 | 216 | 4 | CID000014995 | |
| Drug | colchicide | 7.21e-05 | 24 | 216 | 4 | CID000120712 | |
| Drug | hydroxyl radicals | GALC PDE4C GPAA1 USP11 INPPL1 PFAS INPP4B PTK7 DUSP26 GLB1 PTPRK PTPRS BTD USP32 TIMELESS PLCG1 PADI1 CNDP1 APEX1 SI NCSTN PTPRU CDC14A TRIM9 TM7SF2 PRKCH RIMS1 PADI2 | 7.45e-05 | 1341 | 216 | 28 | CID000000961 |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 8.44e-05 | 189 | 216 | 9 | 3084_UP | |
| Drug | mpMap | 8.52e-05 | 25 | 216 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 8.52e-05 | 25 | 216 | 4 | CID000160263 | |
| Drug | allocolchicine | 8.52e-05 | 25 | 216 | 4 | CID000196989 | |
| Drug | 55623-37-5 | 8.52e-05 | 25 | 216 | 4 | CID006438440 | |
| Drug | MDL 27048 | 8.52e-05 | 25 | 216 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 8.52e-05 | 25 | 216 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 8.52e-05 | 25 | 216 | 4 | CID000043264 | |
| Drug | CA1P | 8.52e-05 | 25 | 216 | 4 | CID006918545 | |
| Drug | peloruside A | 8.52e-05 | 25 | 216 | 4 | CID006918506 | |
| Drug | NSC142227 | 8.52e-05 | 25 | 216 | 4 | CID000073427 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.79e-05 | 190 | 216 | 9 | 7145_DN | |
| Drug | N-(all-trans-retinoyl)-DL-leucine | 8.96e-05 | 2 | 216 | 2 | CID006439237 | |
| Drug | retinoylglycine | 8.96e-05 | 2 | 216 | 2 | CID005379396 | |
| Drug | 3,5-difluorophenol | 8.96e-05 | 2 | 216 | 2 | CID000075928 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.52e-05 | 192 | 216 | 9 | 3929_DN | |
| Drug | NSC527981 | 1.00e-04 | 26 | 216 | 4 | CID000352796 | |
| Drug | NSC332029 | 1.00e-04 | 26 | 216 | 4 | CID000100073 | |
| Drug | indibulin | 1.00e-04 | 26 | 216 | 4 | CID000002929 | |
| Drug | pironetin | 1.00e-04 | 26 | 216 | 4 | CID006438891 | |
| Drug | isaxonine | 1.00e-04 | 26 | 216 | 4 | CID000071169 | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 1.03e-04 | 194 | 216 | 9 | 6199_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 216 | 9 | 4721_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | ABCC3 PTPRS NFKBIB PADI1 CRYBG2 SYNE1 MLLT10 RAB3GAP1 LRRC15 | 1.07e-04 | 195 | 216 | 9 | 3778_DN |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.07e-04 | 195 | 216 | 9 | 4360_DN | |
| Disease | microlissencephaly (implicated_via_orthology) | 6.22e-15 | 8 | 208 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 6.22e-15 | 8 | 208 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 6.22e-15 | 8 | 208 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 6.16e-10 | 27 | 208 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | RELN ABCA13 DGKB NOD2 HPGDS DIO2 TIMELESS PLCG1 CACNA1A WFS1 SYNE1 GRIA3 GRIN2B RFX4 TENM4 RIMS1 IL1B | 5.73e-08 | 477 | 208 | 17 | C0005586 |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.37e-06 | 4 | 208 | 3 | DOID:898 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | MKRN3 ABCC3 ABCA13 SLC22A15 NCDN PTPRS PIGO CNTN1 SELENBP1 SYNE1 PTPRU CDC14A ABCA5 CBX5 WIF1 EPHA3 | 4.22e-05 | 702 | 208 | 16 | C0009402 |
| Disease | Parkinson disease | ZNF165 HLA-DRA TMC3 CHRNB1 NOD2 PJA1 CNTN1 COL12A1 RFX4 RIMS1 | 1.02e-04 | 321 | 208 | 10 | MONDO_0005180 |
| Disease | schizophrenia (implicated_via_orthology) | 1.21e-04 | 68 | 208 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | red wine liking measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0006947 | |
| Disease | vision disorder | 1.81e-04 | 16 | 208 | 3 | MONDO_0021084 | |
| Disease | Van Buchem disease | 2.18e-04 | 17 | 208 | 3 | C0432272 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.94e-04 | 4 | 208 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.94e-04 | 4 | 208 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 2.94e-04 | 4 | 208 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 2.94e-04 | 4 | 208 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.94e-04 | 4 | 208 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.94e-04 | 4 | 208 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | bipolar disorder (is_marker_for) | 3.08e-04 | 19 | 208 | 3 | DOID:3312 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.60e-04 | 20 | 208 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | cortical thickness | IL34 PALD1 RELN ADGRV1 NRP1 ANGPT4 PKD1 CLUH COL11A1 COL12A1 MLLT10 PNKD RFX4 JMJD1C SH3PXD2A LRP11 TNS1 MYO16 EPHA3 | 3.62e-04 | 1113 | 208 | 19 | EFO_0004840 |
| Disease | Mental Depression | 4.67e-04 | 254 | 208 | 8 | C0011570 | |
| Disease | trochanter size | 4.88e-04 | 5 | 208 | 2 | EFO_0010074 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.88e-04 | 195 | 208 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | forced expiratory volume | GDF5 HLA-DRA DGKB IREB2 CHRNB2 PIK3C2B FER DIO2 BOP1 SYNE1 JMJD1C SH3PXD2A LRP5 TNS1 MYBPC1 | 5.13e-04 | 789 | 208 | 15 | EFO_0004314 |
| Disease | Acute Confusional Senile Dementia | 6.94e-04 | 99 | 208 | 5 | C0546126 | |
| Disease | Alzheimer Disease, Late Onset | 6.94e-04 | 99 | 208 | 5 | C0494463 | |
| Disease | Alzheimer's Disease, Focal Onset | 6.94e-04 | 99 | 208 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 6.94e-04 | 99 | 208 | 5 | C0750901 | |
| Disease | Presenile dementia | 6.94e-04 | 99 | 208 | 5 | C0011265 | |
| Disease | Familial Alzheimer Disease (FAD) | 7.26e-04 | 100 | 208 | 5 | C0276496 | |
| Disease | keratoconus (is_implicated_in) | 7.28e-04 | 6 | 208 | 2 | DOID:10126 (is_implicated_in) | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 7.28e-04 | 6 | 208 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | Lissencephaly | 7.28e-04 | 6 | 208 | 2 | cv:C0266463 | |
| Disease | Malformation of cortical development | 7.28e-04 | 6 | 208 | 2 | cv:C1955869 | |
| Disease | Alzheimer's Disease | 7.59e-04 | 101 | 208 | 5 | C0002395 | |
| Disease | Colorectal Neoplasms | 8.23e-04 | 277 | 208 | 8 | C0009404 | |
| Disease | Seizures | 9.41e-04 | 218 | 208 | 7 | C0036572 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 9.72e-04 | 62 | 208 | 4 | DOID:9074 (is_implicated_in) | |
| Disease | Sleep Wake Disorders | 1.01e-03 | 7 | 208 | 2 | C4042891 | |
| Disease | Sleep Disorders | 1.01e-03 | 7 | 208 | 2 | C0851578 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 1.01e-03 | 7 | 208 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | Hidradenitis Suppurativa | 1.01e-03 | 7 | 208 | 2 | C0162836 | |
| Disease | Subwakefullness Syndrome | 1.01e-03 | 7 | 208 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 1.01e-03 | 7 | 208 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 1.01e-03 | 7 | 208 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 1.01e-03 | 7 | 208 | 2 | C0751508 | |
| Disease | Depressive disorder | 1.08e-03 | 289 | 208 | 8 | C0011581 | |
| Disease | waist-hip ratio | GDF5 DGKB PTK7 NRP1 HOXC13 PIK3C2B PTPRS BTD PKD1 DMXL2 COL11A1 DCUN1D5 GRIN2B MLLT10 PNKD RFX4 JMJD1C RIMS1 EPHA3 | 1.15e-03 | 1226 | 208 | 19 | EFO_0004343 |
| Disease | Epileptic encephalopathy | 1.22e-03 | 30 | 208 | 3 | C0543888 | |
| Disease | cervical cancer (is_implicated_in) | 1.22e-03 | 30 | 208 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | intertrochanteric region size | 1.35e-03 | 8 | 208 | 2 | EFO_0010075 | |
| Disease | Large cell carcinoma of lung | 1.47e-03 | 32 | 208 | 3 | C0345958 | |
| Disease | Schizophrenia | RELN ABCA13 FASTKD5 CHRNB2 HP HPGDS SELENBP1 GRIA3 GRIN2B TENM4 CSF2RB MTOR SH3PXD2A IL1B MYO16 | 1.58e-03 | 883 | 208 | 15 | C0036341 |
| Disease | word list delayed recall measurement, memory performance | 1.61e-03 | 33 | 208 | 3 | EFO_0004874, EFO_0006805 | |
| Disease | brain measurement, neuroimaging measurement | IL34 GDF5 NRP1 TUBA1B COL11A1 MLLT10 PNKD RFX4 SH3PXD2A TNS1 EPHA3 | 1.92e-03 | 550 | 208 | 11 | EFO_0004346, EFO_0004464 |
| Disease | squamous cell carcinoma, esophageal carcinoma | 2.14e-03 | 10 | 208 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | Renal Cell Carcinoma | 2.18e-03 | 128 | 208 | 5 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.18e-03 | 128 | 208 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.18e-03 | 128 | 208 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.18e-03 | 128 | 208 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.18e-03 | 128 | 208 | 5 | C1306837 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.50e-03 | 80 | 208 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 2.61e-03 | 11 | 208 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Graves' disease (is_implicated_in) | 2.62e-03 | 39 | 208 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | Autistic Disorder | 2.62e-03 | 261 | 208 | 7 | C0004352 | |
| Disease | systemic juvenile idiopathic arthritis | 2.81e-03 | 40 | 208 | 3 | EFO_1001999 | |
| Disease | peak expiratory flow | GDF5 TP53INP2 INPP4B PTPRK PIK3C2B PKD1 GGACT COL11A1 TBCK LRP5 | 2.96e-03 | 498 | 208 | 10 | EFO_0009718 |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.11e-03 | 85 | 208 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | Hereditary hemochromatosis | 3.12e-03 | 12 | 208 | 2 | C0392514 | |
| Disease | phenylacetate measurement | 3.12e-03 | 12 | 208 | 2 | EFO_0021012 | |
| Disease | Congenital muscular dystrophy | 3.12e-03 | 12 | 208 | 2 | cv:C0699743 | |
| Disease | Hemochromatosis | 3.12e-03 | 12 | 208 | 2 | C0018995 | |
| Disease | alcohol consumption measurement | RELN ADGRV1 INPP4B ACOD1 PTPRK PLEKHM2 DIO2 KLB CACNA1A COL12A1 NAA11 GPRC6A GRIN2B LRPPRC MTOR CBX5 EIF2B1 EPHA3 | 3.17e-03 | 1242 | 208 | 18 | EFO_0007878 |
| Disease | colitis (biomarker_via_orthology) | 3.24e-03 | 42 | 208 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | brain volume measurement | IL34 GDF5 RELN CACNA1A GRIN2B MLLT10 PNKD RFX4 SH3PXD2A WIF1 EPHA3 | 3.50e-03 | 595 | 208 | 11 | EFO_0006930 |
| Disease | Liver Cirrhosis, Experimental | GALC INPPL1 ITGAL IQGAP1 GK PXDN HPGDS CNDP1 COL6A1 AEN COL12A1 IGF2R IL1B | 3.53e-03 | 774 | 208 | 13 | C0023893 |
| Disease | FVC change measurement, response to placebo | 3.66e-03 | 13 | 208 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | Hereditary hearing loss and deafness | 3.84e-03 | 146 | 208 | 5 | cv:C0236038 | |
| Disease | Disorder of eye | 4.04e-03 | 212 | 208 | 6 | C0015397 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.06e-03 | 148 | 208 | 5 | C0279702 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | alpha-Dystroglycanopathies | 4.26e-03 | 14 | 208 | 2 | C2936406 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 4.26e-03 | 14 | 208 | 2 | C0410174 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 4.26e-03 | 14 | 208 | 2 | C4284790 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 4.26e-03 | 14 | 208 | 2 | EFO_0004708 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 4.26e-03 | 14 | 208 | 2 | C1836373 | |
| Disease | Kawasaki disease (is_marker_for) | 4.26e-03 | 14 | 208 | 2 | DOID:13378 (is_marker_for) | |
| Disease | Muscle eye brain disease | 4.26e-03 | 14 | 208 | 2 | C0457133 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 4.30e-03 | 93 | 208 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Eczema, allergic rhinitis | 4.32e-03 | 215 | 208 | 6 | EFO_0005854, HP_0000964 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 4.89e-03 | 15 | 208 | 2 | C0265221 | |
| Disease | Alzheimer disease, peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 4.89e-03 | 15 | 208 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247, MONDO_0004975 | |
| Disease | osteoarthritis (implicated_via_orthology) | 4.89e-03 | 15 | 208 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.93e-03 | 293 | 208 | 7 | C1708349 | |
| Disease | Stomach Neoplasms | 5.30e-03 | 297 | 208 | 7 | C0038356 | |
| Disease | Tourette syndrome | 5.30e-03 | 50 | 208 | 3 | EFO_0004895 | |
| Disease | Spondyloepiphyseal Dysplasia | 5.56e-03 | 16 | 208 | 2 | C0038015 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 5.56e-03 | 16 | 208 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Schwartz-Jampel Syndrome | 5.56e-03 | 16 | 208 | 2 | C0036391 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WPDTTLQEHFEIYGA | 1386 | Q8WWZ7 | |
| VGNVPLEWYDDFPHV | 136 | Q14137 | |
| EDQYWPDDLAHGSRG | 301 | Q8WTP8 | |
| RKGLHEPYSESDDDW | 2491 | O00555 | |
| LSNYDEDGAWPVLLD | 266 | Q92564 | |
| ESDWIYFHPDASGRI | 341 | Q5H9S7 | |
| WVPIKEYSSEHQAAD | 476 | Q9Y6R9 | |
| RLTWHAYPEDAENKE | 171 | P45973 | |
| EGHPQYLLDSNSWIE | 1696 | P0C0L5 | |
| HYERVENGDFNWIVP | 171 | Q9UNH5 | |
| VGNYSIINWHLSPED | 486 | P41180 | |
| FHRPQAVNGEEWYET | 2311 | Q7Z2Y8 | |
| EIWEGHNIADYIDPA | 431 | Q9BZE4 | |
| LDGIPELDEHYWVVL | 846 | Q8WXG9 | |
| LHWNIDSDPDGDLAF | 1901 | Q8WXG9 | |
| YRLSWDPAEHDGIDS | 86 | P11230 | |
| QDALDELLTGWEHLY | 4806 | Q86UQ4 | |
| PLWVEGAGHNDIELY | 276 | Q96GS6 | |
| HPIQDDSVWYIDDSE | 476 | Q9NU02 | |
| EEPLNLDWGEDHDSA | 1971 | Q8TDJ6 | |
| VWPEEHGEQEHGLYS | 11 | O75618 | |
| AELQELPGLSHQYWS | 106 | P27695 | |
| DTKLSEAVWQPEEHY | 901 | Q9Y485 | |
| LSNYDEDGAWPVLLD | 211 | Q9BTE7 | |
| HWLEPTIYSSEEDGL | 1141 | Q96BY7 | |
| EAHGNLWDILIEATY | 216 | A8MX76 | |
| YYHNLETQEGGWDEP | 696 | P46940 | |
| TLPYSVADLEWDAGH | 181 | Q9Y483 | |
| ASEELPHVYEQSAWG | 216 | Q7Z4M0 | |
| PHVYEQSAWGAEELG | 221 | Q7Z4M0 | |
| NDVYSDLDPIQAPHW | 296 | Q15042 | |
| VELYSDWLSVGHVDE | 461 | Q9ULC6 | |
| EEAFLHWSPQDSLYG | 201 | Q16769 | |
| HLLEEQSPIESYIEW | 386 | Q33E94 | |
| IYIEGQDEPRCLHEW | 326 | Q6P2E9 | |
| GKNIYLHDIWPSREE | 656 | P48200 | |
| NYAPDEDQGHLEDSW | 851 | O15438 | |
| EYSWVQGPLHSNETD | 601 | Q92542 | |
| YHNTEDLWGEPHAVA | 226 | Q9ULE6 | |
| VDPSDWIGLYHIDEN | 86 | Q9P2P5 | |
| PGNEVRYHQWEESLE | 46 | Q8WWY6 | |
| DTWDNEAYVHDAPVR | 106 | P01584 | |
| FLLVYIDEAHPSDGW | 156 | Q92813 | |
| HWILLEDIDYAPLDV | 396 | Q9NU22 | |
| DWIIAPLEYEAFHCE | 416 | P43026 | |
| DDHAIVQYEWALLQG | 236 | Q86VZ4 | |
| VHDLEEDTWYATGIL | 361 | P00738 | |
| ALSPEYEGIWADLQE | 621 | Q9UBB6 | |
| GWVEQDPKEILHSVY | 51 | Q14409 | |
| EHDLLGTEAWLEAYH | 186 | O43292 | |
| GDLNIVDDQYWTPLH | 246 | Q9Y6X6 | |
| ASNEVGEDWLHYELL | 2831 | Q8NDA2 | |
| HLKAYDWGSPDLNLV | 271 | Q5W064 | |
| SEELLWEYVHSGEPM | 156 | O95671 | |
| DAIPSHPREDWYEQL | 566 | O15327 | |
| EVLPEHDPIRDQSWY | 2416 | Q15652 | |
| DIQYEDHRIEQADWP | 26 | O60760 | |
| DSDIYWPNGLTIDLE | 191 | O75197 | |
| PWPGQYQFSEDHDVE | 91 | P16278 | |
| QLSHPDFPDGEYWID | 1611 | P12107 | |
| WKLQLEAENYEGHTP | 196 | Q15653 | |
| QTGQDLKEEHPWVDY | 261 | Q14232 | |
| FSPYEWHLEDNNEEP | 576 | P42263 | |
| AEGYWEELLDTTQPA | 186 | Q9UK22 | |
| SQVGFIDYIAHPLWE | 596 | Q08493 | |
| RDAEAHPWLSDYDDL | 301 | P50542 | |
| HLPRSQVYEDLEGWF | 326 | Q11130 | |
| DWNEPALIDQYHEGL | 196 | Q86TG7 | |
| VPELWYEDEKHSLNS | 1011 | P42704 | |
| TQWDLQPDTDYEIHL | 1076 | P32004 | |
| GYETENLESPEWTLH | 1031 | Q8IWU2 | |
| PEWAQLPHHDSYDSE | 126 | Q9BVM4 | |
| SFQEELLYWGIAEDH | 146 | Q9UIX4 | |
| IEEPEERDGYGRWNH | 346 | Q9UL42 | |
| ELYSDWLTVGHVDEF | 461 | Q9Y2J8 | |
| YWIQGDSESEAHLLD | 1161 | P16144 | |
| PSTYIDLAVDEHGLW | 266 | Q6UWY5 | |
| ELEYSVDLGLSWHPL | 2396 | P78509 | |
| WIDGNTALHRDIYPS | 276 | Q96NX5 | |
| EYESIDPGQQFTWEH | 1396 | Q13332 | |
| YDDFQWEQVRIHPGT | 46 | Q92729 | |
| LADWLQKHNPGEDEY | 1156 | O00750 | |
| IELETALLDDEPHWY | 851 | Q86UR5 | |
| LLYVGDALWHEEAVL | 231 | O76062 | |
| DFLWDYAEPGLIHSI | 401 | Q5T6X5 | |
| APHSYINEWLQIDLG | 476 | O14786 | |
| EDFLQLHEDWHYCGP | 881 | Q99575 | |
| EDDLPHHEERTWYVG | 611 | O00459 | |
| VVPNWHESAEGKEYL | 11 | Q9BU20 | |
| LDSIAHGNRLTPYDW | 336 | Q9HDB9 | |
| LYGEFDLLTHEWTDG | 1911 | Q9P2D7 | |
| HLQQEGSELLWYLAE | 536 | Q7L8L6 | |
| EGHPSWKYLQEVETL | 111 | Q6ZMJ4 | |
| SHWLSPGDLEFEVVY | 161 | P32927 | |
| PADHDPIHDQSWYLD | 1201 | Q9Y4C1 | |
| YNTDTDEWERDLHFP | 581 | Q53HC5 | |
| VYDCQVEHWGLDAPL | 186 | P06340 | |
| WNAGALHYSDEVEII | 86 | P12109 | |
| EDYGRQWAENVENHP | 66 | Q8WXQ3 | |
| LSVAWDHADGPVQQY | 2041 | Q99715 | |
| LYLVDAFSAWHQEEP | 181 | Q96MS3 | |
| SEKPLAEQDWYHGAI | 451 | P16591 | |
| AEQDWYHGAIPRIEA | 456 | P16591 | |
| HINDTEVDIGSDLYW | 336 | Q12860 | |
| GYDRDHVVLWEPDED | 1636 | Q8N1P7 | |
| IRENGSPEEHAIYVW | 261 | Q8WUF8 | |
| QDLTDYGELSDWSLP | 206 | Q14213 | |
| QEFPWEEEYRSALHT | 796 | Q9NSG2 | |
| IDYDHDGTVSLEEWI | 206 | Q9Y6T7 | |
| GWVEQDPKEILHSVY | 51 | P32189 | |
| LEVPDQLGWENDHYF | 506 | P43251 | |
| PVYELSGEHHDEEWS | 251 | Q9NZK5 | |
| YSLRVELQDWEGHEA | 376 | Q9Y264 | |
| YDCRVEHWGLDEPLL | 186 | P01903 | |
| SWQEPEHPNGIILDY | 456 | P29320 | |
| DALIPVEGYQHWALS | 206 | P31276 | |
| YDPHDWDAEDLQVFV | 156 | P49641 | |
| YGHWRKPLSQEDLEE | 406 | A6NK06 | |
| LPNDEIWTYDIDSGL | 41 | Q8N7A1 | |
| SLHADWAEPANPYAD | 741 | Q86Z14 | |
| SHEDPEVQFNWYVDG | 146 | P01859 | |
| ARHGDIIPWDYDVDL | 351 | Q9H9S5 | |
| DGYEWDPDSQHCRDV | 41 | O95967 | |
| HDLDIDYIGIWNERS | 186 | P54803 | |
| AASPHYQEWILDTID | 26 | Q6SPF0 | |
| LVGATPSYHWDLAEL | 41 | Q8IZD6 | |
| YLWEHIFEGLLDPSD | 111 | Q9Y2B1 | |
| GIDSEEIQAIHWIYP | 2871 | Q6ZTR5 | |
| HDLSWTPYEDIEKQD | 156 | Q9BV19 | |
| EGHPQYLLDSNSWIE | 1696 | P0C0L4 | |
| DSRDLGHPVYGEEAW | 146 | Q6J272 | |
| TGWHDAEDAGAPLVY | 2496 | P98161 | |
| LYDDFEWVHVSAQEP | 51 | Q15262 | |
| TVRFYGLVHWEDPTD | 741 | Q8IWE5 | |
| FDYGHWPDVNEALVE | 1911 | P42345 | |
| WEAITGTGDPEHYLI | 1391 | P11717 | |
| DEADVFYLNPLNWLH | 471 | Q92521 | |
| DLPGHADEVYAVDWS | 451 | Q9NVX2 | |
| HDAYAIVPSPEWDAE | 376 | Q6NUJ1 | |
| HYQGIDNYPLDWELS | 616 | Q68CR1 | |
| WNEDFEGHLERPAYV | 996 | Q7Z5M5 | |
| RDPGYDHLWDETLSS | 576 | Q494U1 | |
| LGDDTLLWPGHEYAE | 281 | Q8N490 | |
| LLWPGHEYAEENLGF | 286 | Q8N490 | |
| ELPADLQHWISYNEA | 176 | Q8WUY1 | |
| GVELEYILETWSHLD | 6681 | Q8NF91 | |
| IPLEWDHDYDLSRDL | 8281 | Q8NF91 | |
| EEIFAHLGLDYIEPW | 491 | P04053 | |
| RELWLYDNHISSLPD | 296 | Q8TF66 | |
| QDWLPHVEVQSYDSD | 331 | Q9HC36 | |
| IYDPDNETDPFHNIW | 176 | Q9BVG9 | |
| LEELEEIQAYDPEHW | 241 | P0DUX0 | |
| LEELEEIQAYDPEHW | 241 | P0DTA3 | |
| LEELEEIQAYDPEHW | 241 | P0DUD1 | |
| ERYEEGLVHNGWDDL | 1211 | O15357 | |
| EGILIVWDPSVYHSD | 251 | P15907 | |
| NWLHGDLRQYDISDP | 326 | Q13228 | |
| PVLHEFYEDTNSWIE | 716 | P14410 | |
| EEDAYWVQLDLHFPP | 811 | P20701 | |
| ENYLEATVWIHGDNE | 256 | Q9Y2L1 | |
| LLGDEYDAPAVDIWS | 186 | Q9NRH2 | |
| HADEVWPGLYLGDQD | 61 | Q9BV47 | |
| VAWAPDTDDEKPHQY | 126 | Q8N4L4 | |
| LVEERPYDHTADLWS | 171 | Q9NRP7 | |
| DKELYGPDNHLVEWH | 261 | Q92925 | |
| HIWLPDVVLYNNADG | 111 | P17787 | |
| PLWVEGAGHNDVELY | 256 | Q5VST6 | |
| VPVDATHYLAEGWLF | 101 | P32247 | |
| ERGWAENPLVYCDGH | 31 | P55197 | |
| EWIFPENADHISYLA | 296 | Q6ZVT6 | |
| APEDAPGVQELYTHW | 431 | Q9H6Q4 | |
| HLWQALYPGDAESLQ | 136 | Q9NS84 | |
| HPWIANIDDTQYLAA | 416 | Q96KN2 | |
| YEEHIPGQTRDWNEE | 346 | O75153 | |
| DPEEDAPVLDWFYDH | 196 | Q6P2Q9 | |
| YGADIHQRDEAGWTP | 86 | Q86WC6 | |
| WELYCLEHGIQPDGQ | 21 | P0DPH8 | |
| TWSPEEEAHLRELYL | 821 | Q9UNS1 | |
| DIHYWIGQDSSLDEQ | 61 | P09327 | |
| GEHWDYDALFETQPG | 216 | Q8NHY6 | |
| WLPDSVAYHADDGKL | 111 | Q8NCJ5 | |
| WENVYDEPDGIHSLS | 631 | Q86Y38 | |
| LDGHLLEPDAEYLHW | 221 | Q96DV4 | |
| PFSEDQWDLLHYELE | 486 | Q13064 | |
| LSWPQLSYIAEDEDG | 36 | Q9BSU3 | |
| LSWEDYEGFHLLGQP | 66 | Q9HC29 | |
| EVDGWLIIDLPDSYA | 31 | Q8IXH6 | |
| DSPPDSQHYEDQVHW | 421 | Q9H310 | |
| GENLQDVLPHELYWR | 106 | A6NFA1 | |
| LEELEEIQAYDPEHW | 241 | P0DUX1 | |
| LEELEEIQAYDPEHW | 241 | A0A494C0Z2 | |
| LEELEEIQAYDPEHW | 241 | P0DUD3 | |
| LEELEEIQAYDPEHW | 241 | P0DUD4 | |
| LEELEEIQAYDPEHW | 241 | P0DUD2 | |
| EGWAPSHYLVLDENE | 886 | Q5TCZ1 | |
| PLHWADDDGNPTEQY | 1256 | O15067 | |
| DPLIRWDSYDNFSGH | 331 | Q9HBL0 | |
| WELYCLEHGIQPDGQ | 21 | P0DPH7 | |
| ELLKLNPHWDGDTIY | 1001 | Q92626 | |
| LSYQPEELEWDSPHR | 176 | Q5T6S3 | |
| KNGILYLEDPVNHEW | 491 | P19174 | |
| YDVLAGRWTSPDHEL | 2421 | Q6N022 | |
| WQSAHPATVEDYIGI | 746 | P55017 | |
| RHTLVADPYEEAWNQ | 651 | P19634 | |
| EYEVLPNGCEAHWEV | 196 | Q9NVG8 | |
| PQEESLYLWIDAHQA | 31 | Q9Y5W5 | |
| AEPELELSDYPWFHG | 406 | O14492 | |
| VVSHPDLVYWQGLDS | 536 | Q8TEA7 | |
| LYLWQGHQATADEIE | 436 | O15195 | |
| WELTVDRYDNHPDPA | 581 | Q9C026 | |
| QAWVHEHYPESGEEA | 106 | P49910 | |
| PYSILEELWKDDEHT | 111 | Q5JVG2 | |
| ILEHLYPTMDSGEWD | 211 | Q8TEQ8 | |
| LEELEEIQAYDPEHW | 241 | A0A494C191 | |
| WELYCLEHGIQPDGQ | 21 | Q71U36 | |
| WELYCLEHGIQPDGQ | 21 | Q6PEY2 | |
| WELYCLEHGIQPDGQ | 21 | P68363 | |
| LEEGEIPWLQYHEND | 456 | Q8NG27 | |
| IPWLQYHENDSSSEG | 461 | Q8NG27 | |
| VHVYWLLDGAPVQDT | 61 | Q13308 | |
| PDLDFHQGRLYWSDL | 126 | Q9UP52 | |
| HSDWIPYSVLDDEGR | 6 | P50607 | |
| EVHAQPYIAIDWEPE | 736 | P51784 | |
| WELYCLEHGIQPDGQ | 21 | Q9BQE3 | |
| GNAYIAVDWDPTALH | 1191 | Q8NFA0 | |
| WELYCLEHGIQPDGQ | 21 | P68366 | |
| ELYWDPGHIKQAEDR | 416 | Q5FWF4 | |
| LQEHSYNPGELWGDI | 321 | A6NNM8 | |
| EQAEVNFGWNHLEPY | 391 | O76024 | |
| EWNLISHPTDYQGEI | 371 | Q5VV43 | |
| VSYHWEEINGPFIEE | 466 | Q5VV43 | |
| ILNDEVVYPTWLHED | 566 | P24723 | |
| GEAAYDLPAEDWIVA | 771 | Q00872 | |
| YELNVQDYDGWTPLH | 241 | O60237 | |
| ENSPHWEHVDLTDIY | 1141 | Q13224 | |
| LDDGLEWNHTDIYAN | 166 | P29120 |